Here are 4 forces that drove a tough week for stocks
It was a tough week for stocks as investors navigated everything from rising tensions in the Middle East to key…
It was a tough week for stocks as investors navigated everything from rising tensions in the Middle East to key…
Every weekday, CNBC's Investment Club with Jim Cramer hosts a livestream “morning meeting” at 10:20 a.m. ET. Here's a recap…
CNBC's Jim Cramer said Monday that investors should not fear the latest market rotation. Instead, he believes he is creating…
modern Expanding the portfolio beyond infectious diseases is giving investors a new reason to own stocks after years of uncertainty…
AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop drugs faster and make smarter decisions throughout the research…
Obesity drug giant Eli Lilly reported a monster first quarter on Thursday, strengthening our conviction to hold the stock after…
We've taken a closer look at Cardinal Health's quarterly results and Thursday's post-settlement conference call. Our conclusion: The 4.9% drop…
CNBC's Jim Cramer said Thursday that investors should look beyond the market's hottest trades and start looking for opportunities in…
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Eli Lilly shares fell 6% on Tuesday and are on track for their worst day since February after a downgrade…